RxSight, Inc.
Develops a light-adjustable lens for customized vision correction after cataract surgery.
RXST | NDAQ
Overview
Corporate Details
- ISIN(s):
- US78349D1072
- LEI:
- Country:
- United States of America
- Address:
- 100 COLUMBIA STREET, 92656 ALISO VIEJO
- Website:
- https://www.rxsight.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving vision for patients following cataract surgery. The company develops, manufactures, and commercializes the Light Adjustable Lens (LAL®), the first and only intraocular lens (IOL) system that can be customized non-invasively after implantation. This proprietary technology allows surgeons to optimize and adjust a patient's vision by using a companion Light Delivery Device (LDD) to modify the lens once the eye has healed. The LAL platform aims to provide LASIK-like accuracy in cataract surgery, offering highly predictable and individualized visual outcomes by correcting residual refractive errors, including low levels of astigmatism.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all RxSight, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for RxSight, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for RxSight, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Spermosens_AB_publ-logo.jpg){kind=logo}
